Fri.Oct 08, 2021

Relay's targeted cancer drug could be safer than its competitors. Is it more effective?

Bio Pharma Dive

Initial study results for Relay's experimental treatment offer some support for the biotech's protein motion technology, but raise some questions, too

A novel neural network to understand symmetry, speed materials research

Scienmag

Understanding structure-property relations is a key goal of materials research, according to Joshua Agar, a faculty member in Lehigh University’s Department of Materials Science and Engineering.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Twin Health raises $140m for “digital twin” diabetes reversal app

Pharma Phorum

The developer of a toolkit that promises to create a “digital twin” of individuals with chronic metabolic diseases like diabetes to help model the impact of lifestyle changes has secured $140 million in funding to develop the technology.

TTUHSC researcher investigates ways to enhance neurolysin activity in the brain

Scienmag

Ischemic stroke, the second leading cause of death worldwide, occurs when a vessel to the brain is blocked, reducing blood flow to the brain and depriving it of critical supplies of oxygen and nutrients.

Medtronic Expands Two Insulin Pump Recalls, Including One Over Cybersecurity Concerns

XTalks

Medtronic has expanded a Class I recall of remote controllers used with the MiniMed 508 insulin pump or the MiniMed Paradigm family of insulin pumps over potential cybersecurity risks. The affected remote controller models are MMT-500 and MMT-503.

Oncotarget: Scent test to screen for early-stage pancreatic cancer

Scienmag

Oncotarget published “Scent test using Caenorhabditis elegans to screen for early-stage pancreatic cancer” which reported that although early detection and diagnosis are indispensable for improving the prognosis of patients with pancreatic cancer, both have yet to be achieved.

76

Fungus-derived cancer killing drug by Oxford University shows promise

Pharma Times

A chemotherapy drug, NUC-7738, which is derived from a Himalayan fungus has been found to have 40 times greater potency in killing cancer cells than its original parent compound

Drugs 88

More Trending

Poolbeg Pharma launches AI programme with Eurofins Genomics

Pharma Times

London-based infectious disease pharmaceutical company, Poolbeg Pharma, has announced their deal with testing and support specialist, Eurofins Genomics, according to Proactive Investors

FDA approves innovative treatment for pediatric patients with congenital athymia

The Pharma Data

Today, the U.S. Food and Drug Administration approved Rethymic for the treatment of pediatric patients with congenital athymia, a rare immune disorder. Rethymic is the first thymus tissue product approved in the U.S.

Enzyvant Receives FDA Approval for RETHYMIC® (allogeneic processed thymus tissue-agdc), a One-Time Regenerative Tissue-Based Therapy for Pediatric Congenital Athymia

BioTech 365

Georgia Tech researcher earns $12 million NSF grant to establish atmospheric measurement network

Scienmag

For Second Time, Humana Tennessee Medicare Advantage HMO Plan Achieves Highest Quality Rating

BioTech 365

For Second Time, Humana Tennessee Medicare Advantage HMO Plan Achieves Highest Quality Rating For Second Time, Humana Tennessee Medicare Advantage HMO Plan Achieves Highest Quality Rating Humana members in the statewide plan are enrolled in a plan with a 5 … Continue reading → Business Wire

52

A rare feat: Material protects against both biological and chemical threats

Scienmag

A Northwestern University research team has developed a versatile composite fabric that can deactivate both biological threats, such as the novel coronavirus that causes COVID-19, and chemical threats, such as those used in chemical warfare.

Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital

BioTech 365

Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General … Continue reading → Business Wire

52

Biblical burning

Scienmag

Could the biblical description of the destruction of Sodom be explained by an exploding meteor? Credit: Rhett Butler/East Carolina University Could the biblical description of the destruction of Sodom be explained by an exploding meteor?

Genentech’s Anti-Amyloid Beta Antibody Gantenerumab Granted FDA Breakthrough Therapy Designation in Alzheimer’s Disease

BioTech 365

COVID-19 leads to African agricultural innovation

Scienmag

In a paper published in Advances in Food Security and Sustainability, researchers found that farmers in East Africa (Burundi, Democratic Republic of Congo (DRC), Ethiopia, Kenya, Tanzania, and Uganda) were able to better adapt to the impact of COVID-19 than those in the Southern African countries of Malawi, Zambia, and Zimbabwe.

bluebird bio Provides Update on Upcoming Planned Business Separation

BioTech 365

bluebird bio Provides Update on Upcoming Planned Business Separation bluebird bio Provides Update on Upcoming Planned Business Separation – Company shares detail on stock distribution ratio and planned cash allocation – – New board members appointed – CAMBRIDGE, Mass.–(BUSINESS

52

nTIDE September 2021 Jobs Report: Job numbers surpass pre-pandemic levels for people with disabilities

Scienmag

OrganaBio Adds Perinatal and Adult Tissues for Clinical Manufacturing to its Portfolio of Products for Allogeneic Cell Therapy Development

BioTech 365

Study examines diversifying STEM research for underrepresented students

Scienmag

The social, economic, and health impacts of the COVID-19 pandemic have disproportionately affected underserved populations in the United States, including racially minoritized students, lower-income students, and females.

Ad hoc announcement pursuant to Art. 53 LR: Genentech’s Anti-Amyloid Beta Antibody Gantenerumab Granted FDA Breakthrough Therapy Designation in Alzheimer’s Disease

BioTech 365

Ad hoc announcement pursuant to Art. 53 LR: Genentech’s Anti-Amyloid Beta Antibody Gantenerumab Granted FDA Breakthrough Therapy Designation in Alzheimer’s Disease Ad hoc announcement pursuant to Art.

International refugees: From uncertain pasts to promising futures

Scienmag

A better knowledge of the Australian schooling system and a clear understanding of how parents can support their child’s education could ensure the academic success of thousands of refugee children, according to new research from University of South Australia.

CTX-009 (ABL001/ES104) Clinical Data Presented Today at the New Drugs on the Horizon Plenary Session of the 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

BioTech 365

CTX-009 (ABL001/ES104) Clinical Data Presented Today at the New Drugs on the Horizon Plenary Session of the 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics CTX-009 (ABL001/ES104) Clinical Data Presented Today at the New Drugs on the Horizon … Continue reading → Business Wire

Drugs 52

Sequencing the unknown made easy: Metaplatanus improves metagenome assembly

Scienmag

Metagenomics often involves sequencing DNA samples that can only be described as “tricky.” Such DNA shows high heterogeneity, which can cause interspecies misassemblies.

DNA 52

Pear Therapeutics to Participate in HLTH 2021 Conference and Evercore ISI Digital Therapeutics Virtual Bus Tour

BioTech 365

Pear Therapeutics to Participate in HLTH 2021 Conference and Evercore ISI Digital Therapeutics Virtual Bus Tour Pear Therapeutics to Participate in HLTH 2021 Conference and Evercore ISI Digital Therapeutics Virtual Bus Tour BOSTON–(BUSINESS WIRE)–Pear Therapeutics, Inc.,

Astrophysicists explain the origin of unusually heavy neutron star binaries

Scienmag

A new study showing how the explosion of a stripped massive star in a supernova can lead to the formation of a heavy neutron star or a light black hole resolves one of the most challenging puzzles to emerge from the detection of neutron star mergers by the gravitational wave observatories LIGO and Virgo. Credit: […].

52

Shares for the Cure: Simplify Introduces Health Care ETF Benefiting Susan G. Komen

BioTech 365

Shares for the Cure: Simplify Introduces Health Care ETF Benefiting Susan G. Komen Shares for the Cure: Simplify Introduces Health Care ETF Benefiting Susan G. Komen The Simplify Health Care ETF, trading under the symbol PINK, will donate all net … Continue reading → Business Wire

52

Studies find mixed results from sage grouse hunting restrictions

Scienmag

A thorough review of the history of sage grouse hunting and populations across the Intermountain West shows that declines in the bird’s numbers have prompted significant reductions in hunting opportunities in recent decades — with mixed results for grouse populations.

Alpha Cognition to Present at LD Micro Main Event

BioTech 365

Alpha Cognition to Present at LD Micro Main Event Alpha Cognition to Present at LD Micro Main Event Presentation on Tuesday, October 12th at 3:00 PM EST VANCOUVER, British Columbia–(BUSINESS WIRE)–$ACOG—Alpha Cognition Inc.

52

NIST, collaborators develop sensitive new way of detecting transistor defects

Scienmag

Researchers at the National Institute of Standards and Technology (NIST) and collaborators have devised and tested a new, highly sensitive method of detecting and counting defects in transistors — a matter of urgent concern to the semiconductor industry as it develops new materials for next-generation devices.

GEHA Announces 2022 Health and Dental Plan Options and New Plan Perk for Select Offerings

BioTech 365

GEHA Announces 2022 Health and Dental Plan Options and New Plan Perk for Select Offerings GEHA Announces 2022 Health and Dental Plan Options and New Plan Perk for Select Offerings Tailored plans meet the unique needs of federal employees, including … Continue reading → Business Wire

52

Engineers 3D-print personalized, wireless wearables that never need a charge

Scienmag

Wearable sensors to monitor everything from step count to heart rate are nearly ubiquitous.

Novanta Renames Newly Acquired Company Novanta IMS, Highlights Opportunities Ahead

BioTech 365

Novanta Renames Newly Acquired Company Novanta IMS, Highlights Opportunities Ahead Novanta Renames Newly Acquired Company Novanta IMS, Highlights Opportunities Ahead Formerly known as Schneider Electric Motion, Novanta IMS will open new markets and create synergies for its new parent company … Continue reading → Business Wire

CCNY researchers announce photon-phonon breakthrough

Scienmag

New research by a City College of New York team has uncovered a novel way to combine two different states of matter.

2021 Sweet Pharma Day Winner is HDAX Therapeutics!

BioTech 365

2021 Sweet Pharma Day Winner is HDAX Therapeutics! 2021 Sweet Pharma Day Winner is HDAX Therapeutics! MONTRÉAL–(BUSINESS WIRE)–#biotech–AmorChem, BIOQuébec and CQDM, co-organizers of Sweet Pharma Day, are pleased to announce that HDAX Therapeutics is the winner of the 2021 edition.

52

Wyss Center announces new collaboration to improve brain tumor treatment

Scienmag

Geneva, Switzerland – The Wyss Center announced today that it will lead a collaborative project, as part of Wellcome Leap’s Delta Tissue Program, to improve understanding of the brain cancer glioblastoma (GBM) and help develop more effective therapies.